Search for other papers by M Axelstad in
Google Scholar
PubMed
Search for other papers by U Hass in
Google Scholar
PubMed
Search for other papers by M Scholze in
Google Scholar
PubMed
Search for other papers by S Christiansen in
Google Scholar
PubMed
Search for other papers by A Kortenkamp in
Google Scholar
PubMed
Search for other papers by J Boberg in
Google Scholar
PubMed
investigating how male reproduction may be influenced by developmental exposure of rats to the painkiller paracetamol or to mixtures of human relevant environmental EDCs. In addition to a therapeutically relevant dose of paracetamol, a mixture of 8 anti-androgenic
Search for other papers by Lachlan Angus in
Google Scholar
PubMed
Search for other papers by Shalem Leemaqz in
Google Scholar
PubMed
Search for other papers by Olivia Ooi in
Google Scholar
PubMed
Search for other papers by Pauline Cundill in
Google Scholar
PubMed
Search for other papers by Nicholas Silberstein in
Google Scholar
PubMed
Search for other papers by Peter Locke in
Google Scholar
PubMed
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
characteristics. In transfeminine individuals wishing to inhibit androgenic physical characteristics, choice of anti-androgen agent is a common clinical scenario faced by patients and treating clinicians alike. Whilst both anti-androgen agents, cyproterone
Search for other papers by Willem de Ronde in
Google Scholar
PubMed
Search for other papers by Diederik L Smit in
Google Scholar
PubMed
Introduction Every now and then a clinical endocrinologist will be visited by a patient that uses anabolic androgenic steroids (AAS) or has been using them in the past. The interaction between doctor and patient may be hampered for a number of
Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA
Veterans Affairs Medical Center, Ann Arbor, Michigan, USA
Search for other papers by Richard J Auchus in
Google Scholar
PubMed
the isolation and therapeutic use of cortisone. Hench, a rheumatologist used the anti-inflammatory properties of cortisone to treat rheumatoid arthritis, with dramatic results. Soon afterward, Thorn and Forsham treated adrenal insufficiency with
Alfred Health, Melbourne, Victoria, Australia
Search for other papers by Pravik Solanki in
Google Scholar
PubMed
Department of General Practice, Melbourne Medical School, The University of Melbourne, Victoria, Australia
Search for other papers by Beng Eu in
Google Scholar
PubMed
Search for other papers by Jeremy Smith in
Google Scholar
PubMed
Search for other papers by Carolyn Allan in
Google Scholar
PubMed
Search for other papers by Kevin Lee in
Google Scholar
PubMed
Introduction Anabolic–androgenic steroid (AAS) use is illegal if not prescribed by a medical practitioner ( 1 ). Androgens are abused predominantly by young males trying to improve sporting performance or to increase muscle mass and decrease
Search for other papers by Nancy J Olsen in
Google Scholar
PubMed
Search for other papers by Ann L Benko in
Google Scholar
PubMed
Search for other papers by William J Kovacs in
Google Scholar
PubMed
Introduction Androgenic gonadal steroid hormones exert effects on both human autoimmune disease and the corresponding animal models. In an experimental mouse model of human systemic lupus erythematosus, females acquire fatal renal disease while
Search for other papers by A Daniel Bird in
Google Scholar
PubMed
Search for other papers by Spencer Greatorex in
Google Scholar
PubMed
Search for other papers by David Reser in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Gareth G Lavery in
Google Scholar
PubMed
Search for other papers by Timothy J Cole in
Google Scholar
PubMed
sections with a thickness of 5 μm were cut and mounted on slides, blocked with an appropriate animal serum (5%), then immunostained with donkey anti-HSD1L (sc-1004, Santa Cruz) primary antibodies overnight at 4°C. Supplementary Table 1 (see section on
Search for other papers by Elizabeth Micks in
Google Scholar
PubMed
Search for other papers by Greta B Raglan in
Google Scholar
PubMed
Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA
Search for other papers by Jay Schulkin in
Google Scholar
PubMed
cyproterone acetate, have anti-androgenic and anti-mineralocorticoid activity, possibly leading to desirable non-contraceptive benefits in certain patients (65) . Most data regarding the differences between different progestins are from in vitro biochemical
Search for other papers by Brenda Anguiano in
Google Scholar
PubMed
Search for other papers by Carlos Montes de Oca in
Google Scholar
PubMed
Search for other papers by Evangelina Delgado-González in
Google Scholar
PubMed
Search for other papers by Carmen Aceves in
Google Scholar
PubMed
inhibits the androgenic response in LNCaP cells and reduces the invasive capacity of DU145 and PC-3 cells ( 7 ). These antitumor effects of CRYM/T3 have been explained by a reduction of T3 binding to nuclear receptors ( 7 ). Moreover, it has been proposed
Search for other papers by Yen Kheng Tan in
Google Scholar
PubMed
Search for other papers by Yu Heng Kwan in
Google Scholar
PubMed
Search for other papers by David Choon Liang Teo in
Google Scholar
PubMed
Search for other papers by Marieke Velema in
Google Scholar
PubMed
Search for other papers by Jaap Deinum in
Google Scholar
PubMed
Search for other papers by Pei Ting Tan in
Google Scholar
PubMed
Search for other papers by Meifen Zhang in
Google Scholar
PubMed
Search for other papers by Joan Joo Ching Khoo in
Google Scholar
PubMed
Search for other papers by Wann Jia Loh in
Google Scholar
PubMed
Search for other papers by Linsey Gani in
Google Scholar
PubMed
Search for other papers by Thomas F J King in
Google Scholar
PubMed
Search for other papers by Eberta Jun Hui Tan in
Google Scholar
PubMed
Search for other papers by Shui Boon Soh in
Google Scholar
PubMed
Search for other papers by Vanessa Shu Chuan Au in
Google Scholar
PubMed
Search for other papers by Tunn Lin Tay in
Google Scholar
PubMed
Search for other papers by Lily Mae Quevedo Dacay in
Google Scholar
PubMed
Search for other papers by Keng Sin Ng in
Google Scholar
PubMed
Search for other papers by Kang Min Wong in
Google Scholar
PubMed
Search for other papers by Andrew Siang Yih Wong in
Google Scholar
PubMed
Search for other papers by Foo Cheong Ng in
Google Scholar
PubMed
Search for other papers by Tar Choon Aw in
Google Scholar
PubMed
Search for other papers by Yvonne Hui Bin Chan in
Google Scholar
PubMed
Search for other papers by Khim Leng Tong in
Google Scholar
PubMed
Search for other papers by Sheldon Shao Guang Lee in
Google Scholar
PubMed
Search for other papers by Siang Chew Chai in
Google Scholar
PubMed
Search for other papers by Troy Hai Kiat Puar in
Google Scholar
PubMed
anti-androgenic side effects of MR antagonists. Patient-perceived health outcomes have an increasingly important role in healthcare. One of the most widely used questionnaires is the RAND-36, a generic HRQoL questionnaire which captures multiple